Drugs Made In America Acquisition Corp. is a blank check company. It is an exempt company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on May 23, 2024 and is headquartered in Fort Lauderdale, FL.

Company Data

Name Drugs Made In America Acquisition Corp. - Units

Company Drugs Made In America Acquisition Corp. Units

Symbol DMAAU

Website https://dmaacorp.com

Primary Exchange

NASDAQ

ISIN KYG2847J1206

Asset Class Share

Sector Financial Services

Industry Financial - Conglomerates

CEO Lynn Stockwell

Market Capitalization 248 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address 1 East Broward Boulevard, Suite 700, 33301 Fort Lauderdale

IPO Date 2025-01-27

Ticker Symbols

Name	Symbol
NASDAQ	DMAAU

More Shares

Investors who hold Drugs Made In America Acquisition Corp. - Units also have the following shares in their portfolio:

BMW US CAP 24/26 REGS Bond

PI SOLUTIONS - EUROPEAN CREDIT CONTINUUM - R (C) ETF

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog